Lb Pharmaceuticals (LBRX) Accumulated Depreciation & Amortization (2024 - 2026)
Lb Pharmaceuticals' quarterly Accumulated Depreciation & Amortization came in at $502000.0 in Q1 2026, up 67.33% quarter-over-quarter from $300000.0 in Q4 2025.
Lb Pharmaceuticals has reported Accumulated Depreciation & Amortization for 3 years, with the latest figure at $502000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization changed N/A year-over-year to $502000.0; the trailing twelve-month figure through Mar 2026 stood at $502000.0 (changed N/A YoY), and the FY2025 full-year result was $300000.0, up 200.0% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $502000.0, up from $300000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $502000.0 in Q1 2026, with the low at $100000.0 in Q4 2024.
- Average Accumulated Depreciation & Amortization over 3 years is $309750.0, with a median of $318500.0 recorded in 2025.
- Peak annual rise in Accumulated Depreciation & Amortization reached 200.0% in 2025, while the deepest fall reached 200.0% in 2025.
- Tracing LBRX's Accumulated Depreciation & Amortization over 3 years: stood at $100000.0 in 2024, then jumped by 200.0% to $300000.0 in 2025, then soared by 67.33% to $502000.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $502000.0 (Q1 2026), $300000.0 (Q4 2025), and $337000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lb Pharmaceuticals | 789.92 Mn | 789.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 502,000.00 |
| Mar 31, 2026 | 502,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Dec 31, 2025 | 300,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |